1. Home
  2. CNTX vs DGHI Comparison

CNTX vs DGHI Comparison

Compare CNTX & DGHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • DGHI
  • Stock Information
  • Founded
  • CNTX 2015
  • DGHI 2017
  • Country
  • CNTX United States
  • DGHI United States
  • Employees
  • CNTX N/A
  • DGHI N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • DGHI Finance: Consumer Services
  • Sector
  • CNTX Health Care
  • DGHI Finance
  • Exchange
  • CNTX Nasdaq
  • DGHI Nasdaq
  • Market Cap
  • CNTX 77.2M
  • DGHI 77.6M
  • IPO Year
  • CNTX 2021
  • DGHI N/A
  • Fundamental
  • Price
  • CNTX $0.96
  • DGHI $2.60
  • Analyst Decision
  • CNTX Strong Buy
  • DGHI Strong Buy
  • Analyst Count
  • CNTX 5
  • DGHI 1
  • Target Price
  • CNTX $6.70
  • DGHI $2.50
  • AVG Volume (30 Days)
  • CNTX 1.1M
  • DGHI 305.5K
  • Earning Date
  • CNTX 11-06-2024
  • DGHI 11-15-2024
  • Dividend Yield
  • CNTX N/A
  • DGHI N/A
  • EPS Growth
  • CNTX N/A
  • DGHI N/A
  • EPS
  • CNTX N/A
  • DGHI N/A
  • Revenue
  • CNTX N/A
  • DGHI $42,146,057.00
  • Revenue This Year
  • CNTX N/A
  • DGHI N/A
  • Revenue Next Year
  • CNTX N/A
  • DGHI N/A
  • P/E Ratio
  • CNTX N/A
  • DGHI N/A
  • Revenue Growth
  • CNTX N/A
  • DGHI 100.56
  • 52 Week Low
  • CNTX $0.89
  • DGHI $0.84
  • 52 Week High
  • CNTX $2.75
  • DGHI $2.64
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 38.22
  • DGHI 72.76
  • Support Level
  • CNTX $0.92
  • DGHI $1.41
  • Resistance Level
  • CNTX $1.05
  • DGHI $2.64
  • Average True Range (ATR)
  • CNTX 0.13
  • DGHI 0.20
  • MACD
  • CNTX 0.01
  • DGHI 0.11
  • Stochastic Oscillator
  • CNTX 17.78
  • DGHI 96.34

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About DGHI Digihost Technology Inc. Common Subordinate Voting Shares

Digihost Technology Inc is a blockchain company focused on Bitcoin mining. The company's mining facility is located in Buffalo, New York, and is equipped with an 18.7 MVA 115,000-kilovolt ampere outdoor substation with an option to increase the power output to 42MVA.

Share on Social Networks: